Phillips-Medisize and GlucoModicum team up to deliver a first-of-its-kind, needle-free continuous glucose monitoring device (CGM) that removes patient-care roadblocks by leveraging magnetohydrodynamic (MHD) technology for non-invasive glucose monitoring.
Phillips-Medisize Teams with GlucoModicum to Develop an Innovative Needle-Free Continuous Glucose Monitor
GlucoModicum is an innovative medtech company based in Finland, to design and eventually commercialize a proprietary non-invasive, wearable device that removes technology and patient-care roadblocks to continuous glucose monitoring (CGM).